Literature DB >> 15294962

Induction of IgG2a class switching in B cells by IL-27.

Takayuki Yoshimoto1, Keiko Okada, Noriko Morishima, Sadahiro Kamiya, Toshiyuki Owaki, Masayuki Asakawa, Yoichiro Iwakura, Fumio Fukai, Junichiro Mizuguchi.   

Abstract

IL-27 is a novel IL-12 family member that plays a role in the early regulation of Th1 initiation. However, its role in B cells remains unexplored. We here show a role for IL-27 in the induction of T-bet expression and regulation of Ig class switching in B cells. Expression of WSX-1, one subunit of IL-27R, was detected at the mRNA level in primary mouse spleen B cells, and stimulation of these B cells by IL-27 rapidly activated STAT1. IL-27 then induced T-bet expression and IgG2a, but not IgG1, class switching in B cells activated with anti-CD40 or LPS. In contrast, IL-27 inhibited IgG1 class switching induced by IL-4 in activated B cells. Similar induction of STAT1 activation, T-bet expression and IgG2a class switching was observed in IFN-gamma-deficient B cells, but not in STAT1-deficient ones. The induction of IgG2a class switching was abolished in T-bet-deficient B cells activated with LPS. These results suggest that primary spleen B cells express functional IL-27R and that the stimulation of these B cells by IL-27 induces T-bet expression and IgG2a, but not IgG1, class switching in a STAT1-dependent but IFN-gamma-independent manner. The IL-27-induced IgG2a class switching is highly dependent on T-bet in response to T-independent stimuli such as LPS. Thus, IL-27 may be a novel attractive candidate as a therapeutic agent against diseases such as allergic disorders by not only regulating Th1 differentiation but also directly acting on B cells and inducing IgG2a class switching.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15294962     DOI: 10.4049/jimmunol.173.4.2479

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  Type I cytokine profiles of human naïve and memory B lymphocytes: a potential for memory cells to impact polarization.

Authors:  Alenka Gagro; Drazen Servis; Alma-Martina Cepika; Kai-Michael Toellner; Gillian Grafton; Dale R Taylor; Srecko Branica; John Gordon
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

2.  Cell-intrinsic IL-27 and gp130 cytokine receptor signaling regulates virus-specific CD4⁺ T cell responses and viral control during chronic infection.

Authors:  James A Harker; Aleksandr Dolgoter; Elina I Zuniga
Journal:  Immunity       Date:  2013-08-29       Impact factor: 31.745

Review 3.  Antibody-independent functions of B cells: a focus on cytokines.

Authors:  Ping Shen; Simon Fillatreau
Journal:  Nat Rev Immunol       Date:  2015-06-12       Impact factor: 53.106

4.  Recombinant Lactococcus Lactis Displaying Omp31 Antigen of Brucella melitensis Can Induce an Immunogenic Response in BALB/c Mice.

Authors:  Hoda Shirdast; Fatemeh Ebrahimzadeh; Amir Hossein Taromchi; Yousef Mortazavi; Abdolreza Esmaeilzadeh; Mohammad Hadi Sekhavati; Keivan Nedaei; Esmat Mirabzadeh
Journal:  Probiotics Antimicrob Proteins       Date:  2021-02       Impact factor: 4.609

5.  Interleukin-27 promotes CD8+ T cell reconstitution following antibody-mediated lymphoablation.

Authors:  Katayoun Ayasoufi; Daniel B Zwick; Ran Fan; Suheyla Hasgur; Michael Nicosia; Victoria Gorbacheva; Karen S Keslar; Booki Min; Robert L Fairchild; Anna Valujskikh
Journal:  JCI Insight       Date:  2019-04-04

6.  Signaling events involved in interleukin 27 (IL-27)-induced proliferation of human naive CD4+ T cells and B cells.

Authors:  Pascaline Charlot-Rabiega; Emilie Bardel; Céline Dietrich; Robert Kastelein; Odile Devergne
Journal:  J Biol Chem       Date:  2011-06-13       Impact factor: 5.157

Review 7.  CD11c+ T-bet+ memory B cells: Immune maintenance during chronic infection and inflammation?

Authors:  Gary M Winslow; Amber M Papillion; Kevin J Kenderes; Russell C Levack
Journal:  Cell Immunol       Date:  2017-07-19       Impact factor: 4.868

Review 8.  Interleukin-27: balancing protective and pathological immunity.

Authors:  Christopher A Hunter; Rob Kastelein
Journal:  Immunity       Date:  2012-12-14       Impact factor: 31.745

Review 9.  IL-27-induced modulation of autoimmunity and its therapeutic potential.

Authors:  Rakeshchandra R Meka; Shivaprasad H Venkatesha; Steven Dudics; Bodhraj Acharya; Kamal D Moudgil
Journal:  Autoimmun Rev       Date:  2015-08-05       Impact factor: 9.754

10.  IL27: its roles in the induction and inhibition of inflammation.

Authors:  Joseph W Carl; Xue-Feng Bai
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.